Healthcare -
Biotechnology - NASDAQ - US
$ 4.125
-2.6 %
$ 1.35 B
Market Cap
-3.22
P/E
IOVA - OPERATING EXPENSES
Operating Expenses IOVA - Iovance Biotherapeutics, Inc.
451 M
LAST VALUE
14.72%
2 YEAR CAGR
28.59%
5 YEAR CAGR
34.87%
10 YEAR CAGR